市场调查报告书
商品编码
1211025
吸入和鼻腔外包服务提供商的全球市场规模和预测:按产品、服务和地区分析,2022-2029 年Global Inhaled and Intranasal Products Contract Service Providers Market Size study & Forecast, by Product by Services and Regional Analysis, 2022-2029 |
2021 年全球吸入器和鼻腔产品合同服务提供商市场价值约为 22.1 亿美元,在 2022-2029 年的预测期内健康增长率超过 8.5% 预计将增长
吸入和鼻用产品是专门设计的医疗器械,用于预防哮喘和控製过敏、花粉症和某些鼻部疾病。 服务提供商协议是在提供特定服务的一方与接受该服务的一方之间建立关係以提供专业服务以供考虑的协议。 对有效和先进的呼吸设备的认识不断提高、老年人口不断增加以及监管合规性的简化是全球市场需求的主要驱动力。
慢性呼吸道疾病的增加是市场增长的驱动因素。 世界卫生组织 (WHO) 报告称,呼吸道疾病每年导致约 300 万人死亡(占全球所有死亡人数的 6%),在低收入和中等收入国家,约 90% 的慢性阻塞性肺病死亡人数超过 70 岁。并且是第三大疾病死亡的主要原因。 据估计,大约有 2.62 亿人患有哮喘,这种疾病经常影响儿童。 因此,这些因素与直接吸入和鼻腔产品合同服务提供商的增长有关。 此外,对先进技术开发的投资增加以及基于最新技术的雾化器的推出在预测年内提供了各种有利可图的机会。 然而,在整个 2022-2029 年的预测期内,严格的产品审批政府法规限制了市场增长。
全球吸入器和鼻腔产品合同服务提供商市场研究中考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于呼吸系统疾病的发病率增加、政府举措的增加和多项政策的实施,亚太地区在收入方面占据了市场主导地位。 另一方面,由于有利的保险报销情况和市场空间中存在大量合同製造商等因素,预计北美在预测期内将以最高复合年增长率增长。
这项研究的目的是揭示近年来各个细分市场和国家/地区的市场规模,并预测未来几年的市场规模。 该报告旨在捕捉被调查国家工业的定性和定量方面的情况。
它还提供了关键方面的详细信息,例如决定市场未来增长的驱动因素和挑战。 此外,它还包含供利益相关者投资的微观市场潜在机会,以及对主要参与者的竞争格局和产品供应的深入分析。
Global Inhaled and Intranasal Products Contract Service Providers Market is valued at approximately USD 2.21 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2022-2029. Inhaled and intranasal products is a specially designed medical device that is used for the prevention of asthma and the management of allergy, hayfever, and some nasal conditions. The contract service providers are contract regulates relations in the rendering of professional services between a party which offers the specified service and another the recipient thereof in exchange for a payment. The growing awareness of the effective and advanced respiratory devices, increase in geriatric population, and ease of regulatory compliance are the primary factors that are attributing towards the market demand across the globe.
The increasing incidences of chronic respiratory diseases is acting as a catalyzing factor for the growth of the market. The World Health Organization (WHO) reported that the respiratory disease infections as the third leading cause of mortality, which is accounting for around 3 million deaths year (or 6% of all fatalities worldwide), with nearly 90% of COPD fatalities occurring in individuals over 70 from low- and middle-income nations. Also, there are around 262 million patients were estimated to suffer from asthma, which commonly affects children. Thus, theses aforementioned factors are directly associated growth of the inhaled and intranasal products contract service providers. Moreover, rising investment in the development of advanced technology, as well as the rising launch of the latest technology-based nebulizers are presenting various lucrative opportunities over the forecasting years. However, stringent government regulations for the product approval are a restricting the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Inhaled and Intranasal Products Contract Service Providers Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. The Asia Pacific dominated the market in terms of revenue, owing to the increasing incidences of respiratory disorder, along with the rising government initiatives and implementation of several policies. Whereas, North America is expected to grow with the highest CAGR during the forecast period, owing to factors such as the favorable reimbursement scenario, as well as presence of a large number of contract manufacturers in the market space.
Major market players included in this report are:
Lonza
Catalent Inc.
Kindeva Drug Delivery
Recipharm
Quotient Services
Hovione
Colep
Beximo Pharmaceuticals
DPT Laboratories
Orion
Recent Developments in the Market:
Global Inhaled and Intranasal Products Contract Service Providers Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Product, Services, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Metered - dose Inhalers
Dry Powder Inhalers
Nebulizers
Others
By Services:
Quality Assurance
Regulatory Affair Services
Product Design & Development
Product Maintenance
Contract Manufacturing
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable